Vaxcyte, Inc. PCVX
Super Investor & Insider
2
Fondi che lo detengono
#514
Rank consenso
2.9%
% dei portafogli
$126.5M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | 0.93% | Add 1.74% | 1,377,738 | $80.1M |
| Seth Klarman · Baupost Group | 0.91% | Buy | 800,000 | $46.5M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Vaxcyte Inc. is a biotechnology company focused on developing innovative vaccines for preventing infectious diseases. The primary objective of the company is to create safer and more effective vaccines using its proprietary cell-free protein synthesis platform, a groundbreaking technology that aims to enhance vaccine d…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees507
TickerPCVX
Statistics
Market Cap$7.29B
Revenue (TTM)$0
Net Income-$766.6M
Net Margin—
EPS$-5.63
P/E-8.43
P/S—
P/B2.19
EV/EBITDA-4.61
ROE-30.6%
Dividend Yield—
Price$50.51
Data: Twelve Data · Revenue = mcap / P/S